News - Genzyme

Filter

Current filters:

Genzyme

Popular Filters

64 to 70 of 70 results

Sanofi sets 5% sales growth goal; views Genzyme synergies, patent losses and R&D

07-09-2011

Christopher Viehbacher, chief executive of French drug major Sanofi (Euronext: SAN), says the company…

FinancialGenzymePharmaceuticalResearchSanofi

NIH scientists repurpose Genzyme’s FDA-approved plerixafor for rare disease

05-09-2011

A new study reports that a drug already approved by the US Food and Drug Administration for use in patients…

BiotechnologyGenzymeImmunologicalsMozobilPharmaceuticalPlerixaforRare diseasesResearchSanofi

PTC Therapeutics and Genzyme restructuring ataluren collaboration

04-09-2011

Privately-held PTC Therapeutics and fellow USA-based Genzyme, now part of French drug major Sanofi (Euronext:…

atalurenGenzymeLicensingPharmaceuticalPTC TherapeuticsRare diseasesSanofi

Shire says Fabry and Gaucher disease studies continue to support patient switches to Replagal and Vpriv

01-09-2011

Ireland-headquartered specialty drug firm Shire (LSE: SHP) reported positive data from several studies…

CerezymeFabrazymeGenzymePharmaceuticalRare diseasesReplagalResearchSanofiShireVpriv

Mixed Ph III results for Sanofi MS drug candidate Lemtrada; EMA to broaden review of Multaq

12-07-2011

French drug major Sanofi (Euronext: SAN) and its US biotech subsidiary Genzyme have announced mixed top-line…

AlemtuzumabBiotechnologyCardio-vascularEuropeGenzymeLemtradaMultaqPharmaceuticalRegulationResearchSanofi

Sanofi-Aventis net profit in 1st-qrt 2011 slumps 29%, battered by generics and low flu sales

29-04-2011

French drug major Sanofi-Aventis (Euronext: SAN) posted first-quarter 2011 results yesterday, showing…

BiotechnologyFinancialGenzymePharmaceuticalSanofi-Aventis

64 to 70 of 70 results

Back to top